ClinicalTrials.gg
RecruitingNCT07496099Updated Aug 28, 2026

Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome

An interventional study of post isometric relaxation and MYOFASCIAL RELEASE in Low Back Pain, Mechanical, Lower Cross Syndrome and Hamstring Muscle Tightness, sponsored by University of Karachi. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by University of Karachi · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the combined effects of post-isometric relaxation and myofascial release on pain, flexibility, and functional disability in individuals with low back pain associated with lower cross syndrome. Eligible participants aged 18 to 45 years will be randomly allocated into two parallel intervention groups. One group will receive post-isometric relaxation combined with myofascial release, while the comparison group will receive conventional stretching combined with Therapeutic modalities. Outcomes will be assessed at baseline and after completion of the intervention period. The results of this study are expected to contribute to evidence-based physiotherapy management of low back pain associated with postural imbalance.

02

Conditions studied

  • Low Back Pain, Mechanical
  • Lower Cross Syndrome
  • Hamstring Muscle Tightness

Browse trials for

Keywords

  • Hamstring Tightness
  • Post-Isometric Relaxation with Myofascial Release
  • low back pain with lower cross syndrome
03

In context

Low Back Pain

2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.

This study's planned enrollment of 60 is close to the median of 60 across 2,364 interventional studies indexed under Low Back Pain.

Browse Low Back Pain studies →

Lead sponsor

University of Karachi is the lead sponsor of 37 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Participants aged 18-45 years old
  2. having low back pain persisting for at least 4 weeks
  3. with clinical diagnosis of LCS, and hamstring tightness (AKE >15°)

Exclusion criteria

Exclusion Criteria:

  1. Participants with the history of spinal surgery active neurological conditions
  2. systemic disease affecting connective tissue (Rheumatoid arthritis, Systemic lupus erythematosus)
  3. recent lower limb or spinal injury (within 6 months)
  4. pregnancy or inability to lie prone for treatment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Post-Isometric Relaxation and Myofascial Release Group

    Participants in this group will receive post-isometric relaxation combined with myofascial release targeting the hamstring muscles as part of a supervised physiotherapy program.

    Other: post isometric relaxation · Other: MYOFASCIAL RELEASE

  • Active comparator
    Conventional Stretching and modalities Group

    Participants in this group will receive conventional static hamstring stretching combined with therapeutic modalities, including ultrasound or superficial heat, as part of standard physiotherapy care.

    Other: Conventional Static Stretching · Other: Therapeutic Modalities

Interventions

  • Otherpost isometric relaxation

    Post-isometric relaxation will be applied to the hamstring muscles. Participants will be positioned supine with the hip flexed to 90 degrees and will perform a submaximal isometric contraction of the hamstrings against therapist resistance for 5 to 8 seconds, followed by a passive stretch of approximately 10 seconds. The procedure will be repeated three times per limb per session.

  • OtherMYOFASCIAL RELEASE

    Myofascial release will be applied to the hamstring muscles with the participant in a prone position. Sustained manual pressure will be applied along the length of the hamstring muscles using the therapist's hands for approximately 30 seconds per application, repeated multiple times per session to improve tissue extensibility.

  • OtherConventional Static Stretching

    Conventional static stretching of the hamstring muscles will be performed with the participant in a supine position. Each stretch will be held for approximately 30 seconds and repeated three times per limb per session as part of routine physiotherapy management.

  • OtherTherapeutic Modalities

    Therapeutic modalities, including ultrasound therapy or superficial heat application using a heating pad, will be applied prior to stretching to reduce pain and improve tissue extensibility as part of conventional physiotherapy care.

06

What researchers measure

Primary outcomes

  1. Hamstring Flexibility

    Hamstring flexibility will be assessed using Active Knee Extension (AKE) test measured in degrees with a goniometer.

    Time frame: Outcome measures will be assessed at baseline, immediately after the first session, after 36 sessions at 12 weeks (3 months), and after 72 sessions at 24 weeks (6 months)

Secondary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using the Visual Analogue Scale for Pain, a 10-centimeter scale ranging from 0 to 10, where: 0 = no pain 10 = worst imaginable pain Higher scores indicate worse pain intensity.

    Time frame: assessed at baseline, immediately after the first session, after 36 sessions at 12 weeks (3 months), and after 72 sessions at 24 weeks (6 months)

  2. functional flexibility(Straight Leg Raise Test)

    Functional flexibility will be assessed using the Straight Leg Raise (SLR) Test, measured in degrees using a goniometer.

    Time frame: Outcome measures will be assessed at baseline, immediately after the first session, after 36 sessions at 12 weeks (3 months), and after 72 sessions at 24 weeks (6 months)

  3. Posture Assessment (REEDCO Posture Scale)

    Posture will be assessed using the REEDCO Posture Scale, a standardized observational scale used to evaluate body posture. The scale ranges from 0 to 100, where: Lower scores indicate poor posture Higher scores indicate better posture alignment

    Time frame: Outcome measures will be assessed at baseline, immediately after the first session, after 36 sessions at 12 weeks (3 months), and after 72 sessions at 24 weeks (6 months)

07

Study locations

1 of 1 sites recruiting
  • life cure physiotherapy clinic malir cantt, Karachi
    Karachi, Sindh, Pakistan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — De-identified individual participant data (IPD) collected during this study will not be shared with researchers outside the study team. Data sharing is restricted due to institutional policies, ethical considerations, and the need to protect participant confidentiality. All data will be used solely for academic and research purposes as approved by the institutional review board (IRB).

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Feb 2027, 5 months after the start.

Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 5 months is below that.

Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 22, 2026
First posted
Mar 27, 2026
StartActual
Aug 25, 2026
Primary completionEst.
Feb 5, 2027
CompletionEst.
Mar 20, 2027
Last update
Aug 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07496099
Lead sponsor
University of Karachi
Collaborators
IQRA University
Responsible party
Bushra Madad Ali Malik (Principal Investigator, University of Karachi) — Principal investigator
First posted
Mar 27, 2026
Start date
Aug 25, 2026
Primary completion
Feb 5, 2027 (estimated)
Completion
Mar 20, 2027 (estimated)
Last update
Aug 28, 2026

Study contacts

Bushra Madad Ali Malik, MPHIL
Contact
bushramalik0910@gmail.com
+92305 2722589
Aftab Ahmed Mirza Baig, PhD
Contact
dr.aftab@iqra.edu.pk
+923002739920
Basit Ansari, PhD
study chair · University of Karachi
Bushra Madad Ali Malik, DPT
principal investigator · University of Karachi
Aftab Ahmed Mirza Baig, PhD
study director · IQRA University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion